Drug Topics
DECEMBER 4, 2023
An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.
Pharmacy Times
DECEMBER 4, 2023
Three classes of drugs could be 2 to 5 times more effective than ibuprofen for the treatment of migraine attacks, according to results of a study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 4, 2023
The Senate health care committee will consider a sweeping bill next week meant to combat the opioid epidemic, according to four lobbyists and a congressional aide familiar with the legislation. The proposal would reauthorize a number of programs first created by the SUPPORT Act, an addiction-focused bill that Congress first passed in 2018. Many of those programs’ authorizations expired earlier this year, however, leading addiction treatment advocates to fret that lawmakers —
Pharmacy Times
DECEMBER 4, 2023
A new hydrogel drug delivery system could change the way diabetes is managed.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
DECEMBER 4, 2023
Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes. The document was supposed to help Novak, then the chief executive of CRISPR Therapeutics, navigate a pressing quandary.
Pharmacy Times
DECEMBER 4, 2023
The study authors note that additional policies to reduce structural stigma against sexual minorities could continue to improve the rate of individuals who initiate PrEP use.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The FDA Law Blog
DECEMBER 4, 2023
By Larry K. Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. On October 10th, based on ability to pay, the U.S. District Court for the Western District of Texas imposed a $275,000 civil penalty on Zarzamora Healthcare LLC, in San Antonio, and its pharmacist-owner.
STAT
DECEMBER 4, 2023
WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday. The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September.
Pharmacy Times
DECEMBER 4, 2023
Although personality was linked to cognitive performance on tests, it was not linked to dementia pathophysiology.
STAT
DECEMBER 4, 2023
The medical community today faces a deceptively simple question: How quickly should we act when a child’s life is on the line? I’m a pediatric oncologist, so my answer won’t surprise you — I think we should act immediately. But a new Food and Drug Administration policy could delay things for children who need treatment now.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
DECEMBER 4, 2023
Five years ago, Liya Shuster-Bier entered cancer as an otherwise healthy 29-year-old. | Maia Oncology raised $4.25 million in seed funding to hone its go-to-market strategy, hire more talent and launch its first pilot in partnership with a cancer center and health insurance company.
STAT
DECEMBER 4, 2023
In the wake of the Covid-19 pandemic, the Food and Drug Administration inspected far fewer domestic and foreign pharmaceutical facilities, even though manufacturing activity did not decline, according to a new analysis. Meanwhile, FDA budgeting and staffing held steady, although resources allocated for each inspection surged and more plants were cited for serious violations.
pharmaphorum
DECEMBER 4, 2023
Uveal melanoma: A new generation of therapies offers hope for patients Mike.
Fierce Healthcare
DECEMBER 4, 2023
Northwell Health has teamed up with New York City organizations to launch a new pilot program that aims to improve healthcare services for young adults transitioning out of foster care. | Working with the Administration for Children's Services and the Center for Fair Futures’ coaches, the program will enroll 50 to 100 transition-age adults, pairing them with Northwell’s patient navigation services.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 4, 2023
Despite nearly one-third of reversible dementia cases being drug induced, cognitive safety is a neglected aspect of clinical trials.
Drug Topics
DECEMBER 4, 2023
Three poster presented at the ASHP Midyear Clinical Meeting delved deeper into perioperative pain management.
Pharmacy Times
DECEMBER 4, 2023
Pirtobrutinib is the first and only non-covalent BTK inhibitor to be approved by the FDA and is indicated for adult patients who already received at least 2 prior lines of therapy.
pharmaphorum
DECEMBER 4, 2023
UK primary care group adopts digital heart failure pathway Phil.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 4, 2023
The proportion of prescriptions by a 340B-affiliated physician increased from 9.4% in 2013 to 19.3% in 2020, but the prescriptions filled by 340B pharmacies increased from 18.4% to 49.9%.
pharmaphorum
DECEMBER 4, 2023
Undiagnosed dementia in UK needs drastic action, says review Phil.
STAT
DECEMBER 4, 2023
Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. How sickle cell became the first CRISPR’d disease Nearly a decade ago, consultants delivered to Rodger Novak a kind of Sears catalog of human malady: 200 pages, listing dozens of different diseases, each annotated with — from a business standpoint — their best and worst attributes.
pharmaphorum
DECEMBER 4, 2023
Roche has agreed a deal to acquire US biotech Carmot Therapeutics that if consummated will thrust it into the increasingly competitive market for incretin-based therapies for diabetes and obesity. The Swiss pharma group has agreed to pay $2.7 billion upfront in cash when the deal closes, with shareholders in the US company also in line for up to $400 million if the drug programmes covered by the agreement meet various milestones.
STAT
DECEMBER 4, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and refreshing, because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But you knew this would happen, yes? After all, the world, such as it is, somehow keeps spinning. So time to nudge it in a better direction with a fresh cup of stimulation.
pharmaphorum
DECEMBER 4, 2023
AstraZeneca links with Absci on AI for biologics discovery Phil.
Drug Topics
DECEMBER 4, 2023
A poster from ASHP Midyear 2023 demonstrated the effectiveness of liposomal bupivacaine as it is used for cesarean section procedures, regarded as an area with increasing utilization.
pharmaphorum
DECEMBER 4, 2023
Building vs buying: How to best implement data analysis systems in pharma sales Mike.
Drug Topics
DECEMBER 4, 2023
In this conversation from HAS 2023, Randy Falkenrath demystifies the oncology medication management model and explains how specialty pharmacist can help patients access care.
pharmaphorum
DECEMBER 4, 2023
Pfizer drops twice-daily obesity therapy due to side effects Phil.
The Guardian - Pharmaceutical Industry
DECEMBER 4, 2023
Modern medicine makes it seem as if drugs are the only way to deal with diabetes. But what if diet can be a solution? One gray Sunday in the middle of the Covid lockdown, I received an unwelcome call from my family doctor. Until then, for virtually my entire life, I had managed to stay out of a doctor’s office, except for routine checkups. My luck had run out.
Drug Store News
DECEMBER 4, 2023
From humor and words of appreciation to pop-up cards and licensed content, find out what’s popular in greeting cards.
Fierce Healthcare
DECEMBER 4, 2023
The Joint Commission is launching a voluntary certification program for hospitals and critical access hospitals to demonstrate their responsible use of patient’s health data for non-clinical purpos | The accreditation giant wants its Responsible Use of Health Data Certification program to serve as an objective evaluation of whether a hospital is following best practices around secondary use of data.
pharmaphorum
DECEMBER 4, 2023
Merck grabs late-stage oncology drug from China’s Abbisko Phil.
Fierce Healthcare
DECEMBER 4, 2023
Data on Blue Shield of California members may have been exposed due to a vulnerability in the MOVEit file transfer platform. | Data on Blue Shield of California members may have been exposed due to a vulnerability in the MOVEit file transfer platform.
Expert insights. Personalized for you.
211 
Let's personalize your content